ציין מניה או מטבע קריפטוגרפי בשורת החיפוש כדי לקבל סיכום
IHH HEALTHCARE BERHAD
Q0FIHH Healthcare Berhad, an investment holding company, provides healthcare services in Malaysia, Singapore, Turkey, India, China, Japan, Turkey, Europe, and internationally. It provides primary care services, such as outpatient treatment, routine check-ups, vaccinations, preventive care, and patient education services. The company also offers secondary services, including specialist consultation, local surgeries, emergency care, laboratory, diagnostics, and acute treatment services; tertiary care services comprising specialist consultative care, advanced treatment, complex surgery, and inpatient care services; and quaternary care services, such as organ transplants, neurosurgery, cardiac surgery, and reconstructive plastic surgery. In addition, it provides ancillary services, including diagnostics, analytical laboratory testing, therapeutic radiology, physiotherapy, and integrated rehabilitation and advanced molecular diagnostics services. Further, the company offers medical education; train and develop nurses, doctors, allied healthcare professionals, and other medical and healthcare sector professionals; administrative, management, consultancy services; emergency, home, orthopedics, and ambulatory care services; healthcare information systems, web-based applications, and other technology solutions; and real estate investment trust services. Additionally, it provides services for medical diagnostic laboratory tests; develops, constructs, supervises, manages, and leases medical facility buildings and healthcare facilities; provides catering, laundry, and cleaning services for hospitals; and haemodialysis services, as well as imports and wholesales drug and medical materials. The company engages in the letting of properties; and software system integration and application management services. IHH Healthcare Berhad was incorporated in 2010 and is based in Kuala Lumpur, Malaysia. Address: Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia, 59100
Analytics
מחיר יעד של וול סטריט
2.58 SGDיחס רווח למחיר
24.5556תשואת דיבידנד
1.34 %השנה הנוכחית
שנה שעברה
רבעון נוכחי
רבע אחרון
השנה הנוכחית
שנה שעברה
רבעון נוכחי
רבע אחרון
דמויות מפתח Q0F
ניתוח דיבידנדים Q0F
גידול דיבידנד במשך 5 שנים
570 %צמיחה מתמשכת
2 שניםיחס תשלום ממוצע של 5 שנים
56 %היסטוריית דיבידנדים Q0F
שווי מניות Q0F
פיננסיים Q0F
תוצאות | 2019 | דינמיקה |